Clinical trial
Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated…
NCT00491179 · National Taiwan University Hospital, Other · Completed
Key facts
| NCT number | NCT00491179 |
|---|---|
| Title | Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin |
| Official title | Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin Who Fail Interferon Alfa or Pegylated Interferon Alfa Monotherapy - a Pilot Study |
| Lead sponsor | National Taiwan University Hospital, Other |
| Collaborators | National Science and Technology Council, Taiwan Department of Health, Executive Yuan, R.O.C. (Taiwan) |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis C, Hemodialysis |
| Intervention type | Drug |
| Interventions | Pegylated interferon alfa-2a and ribavirin |
| Enrollment | 35 |
| Start date | Jun 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Jun 26, 2007 |
| Last update posted | Nov 13, 2009 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: